Substituted Pyridines Modulating Wnt Signaling Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for agents and methods that effectively modulate the Wnt signaling pathway, particularly as inhibitors to treat, diagnose, prevent, and ameliorate Wnt signaling-related disorders, with the ideal candidates being stable, non-hygroscopic, and easily formulable.
Innovation Solution
The development of specific compounds, such as those represented by Formulas (1), (2), (2A), and (3), which are designed to inhibit the Wnt signaling pathway, offering stability and solubility, and can be administered in pharmaceutical compositions to inhibit Wnt signaling in cells and treat related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Wnt pathway modulators are used, then Wnt signaling can be inhibited, but the compounds suffer from poor stability and solubility
Solution Approach 1:
The patent modifies the chemical parameters of Wnt pathway modulators by introducing specific substituents (halo, cyano, alkoxy, amino, hydroxyl, carboxyl groups) at defined positions on the core molecular structure. These parameter changes optimize both the stability and solubility characteristics of the compounds, making them suitable for pharmaceutical formulation while maintaining their biological activity.
Solution Approach 2:
The invention creates composite molecular structures by combining a core scaffold with various functional substituents. This composite approach allows the molecule to integrate multiple properties: the core provides structural stability and target binding, while the substituents contribute to solubility and pharmacokinetic properties, resolving the contradiction between stability and formulability.
2Reliability
If Wnt signaling is inhibited to treat disorders, then aberrant signaling is reduced, but the compounds must maintain high stability and solubility for effective administration
Solution Approach 1:
The patent systematically varies chemical parameters including the introduction of polar groups (hydroxyl, carboxyl, amino), halogen atoms, and alkoxy chains at specific positions on the molecular scaffold. These parameter modifications directly enhance aqueous solubility while the core structure maintains structural stability, enabling effective drug administration.
Solution Approach 2:
The patent employs solubilizing substituents as intermediary elements that mediate between the hydrophobic core structure and the aqueous biological environment. These intermediary groups (such as alkoxy chains, hydroxyl groups, and carboxyl groups) improve solubility without compromising the stability of the core molecular structure, allowing the compound to function effectively in physiological conditions.
Data Source
AI summary
The present invention relates to compositions and methods for modulating the Wnt signaling pathway, using compounds having Formula (1) and (3): wherein A, B, Y and Z all represent rings, and R1, R2, R3 are as defined herein.